cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sarepta Therapeutics Inc
25 own
27 watching
Current Price
$123.29
$-2.71
(-2.15%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
12,883.99M
52-Week High
52-Week High
173.25000
52-Week Low
52-Week Low
68.00000
Average Volume
Average Volume
1.14M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization12,883.99M
icon52-Week High173.25000
icon52-Week Low68.00000
iconAverage Volume1.14M
iconDividend Yield--
iconP/E Ratio--
What does the Sarepta Therapeutics Inc do?
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD), which is a rare genetic muscle-wasting disease caused by the absence of dystrophin. It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. The company has a strategic alliance with Nationwide Children's Hospital for the advancement of microdystrophin gene therapy program under the research and option agreement, as well as Galgt2 gene therapy program under the license agreement; Catabasis Pharmaceuticals, Inc to explore a combination drug treatment approach for DMD under the research collaboration agreement; and Charley's Fund, Inc. to support the development of product candidates using its proprietary exon-skipping technologies under the research agreement. It also has a license agreement with the University of Western Australia for treatment of DMD by inducing the skipping of certain exons; and collaboration and license agreement with Summit (Oxford) Ltd. for the development of ezutromid, an utrophin modulator which is in phase II clinical trials for the treatment of DMD. The company distributes its products through a network of specialty distributors and specialty pharmacies in the United States. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Sarepta Therapeutics Inc make?
News & Events about Sarepta Therapeutics Inc.
Business Wire
1 year ago
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced it had completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV). Sarepta received a payment of $102 million upon completion of the sale. Sarepta was awarded...
Business Wire
1 year ago
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at Cowen's 2nd Annual RNA Therapeutics Summit on Monday, July 10, 2023 at 11:00 a.m. E.T. The fireside chat will be held...
TipRanks Financial Blog
1 year ago
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sarepta Therapeutics (SRPT Research Report), Int... Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sarepta Therapeutics (SRPT Research Report), Intercept...
Business Wire
1 year ago
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, today announced U.S. Food and Drug Administration (FDA) accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl), an adeno-associated virus based gene therapy for the treatment of...
Benzinga
1 year ago
read more...
Frequently Asked Questions
Frequently Asked Questions
What is Sarepta Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Sarepta Therapeutics Inc shares?
plus_minus_icon
How can I buy Sarepta Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Sarepta Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Sarepta Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Sarepta Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Sarepta Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Sarepta Therapeutics Inc?
plus_minus_icon
What percentage is Sarepta Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Sarepta Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$123.29
$-2.71
(-2.15%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00